Skip to Content

Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma

Download PQI pdf 0.15MB

Last Updated: October 13, 2023

By: Jody Agena, PharmD

About this PQI

Understand how to identify eligible patients and manage adverse effects of regorafenib treatment in hepatocellular carcinoma.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI